KALV•benzinga•
KalVista Pharmaceuticals Has Licensed Commercialization Rights Of Sebetralstat Investigational, Oral On-Demand Treatment For Hereditary Angioedema (HAE) To Kaken Pharmaceutical In Japan
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 8, 2025 by benzinga